Literature DB >> 27619815

Genetic Approach to Diagnosis of Intellectual Disability.

Ratna Dua Puri1, Moni Tuteja2, I C Verma2.   

Abstract

Intellectual disability is a non-specific phenotype present in a genetically heterogeneous group of disorders. It is characterized by deficits in intellectual and adaptive functioning, presenting before 18 y of age. Identifying the cause of ID is important to provide treatment where available, genetic counseling, recurrence risks and reproductive options for subsequent pregnancies. Advances in technology, especially next generation sequencing and microarrays, have greatly increased the diagnostic yield of evaluation in cases of ID. This paper describes the points in history taking and examination in the evaluation of a proband, and discusses the proper use of newer diagnostic technologies.

Keywords:  Etiology; Intellectual disability; Metabolic; Microarray; Next generation sequencing; Single gene disorders

Mesh:

Year:  2016        PMID: 27619815     DOI: 10.1007/s12098-016-2205-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  42 in total

Review 1.  Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  D J Michelson; M I Shevell; E H Sherr; J B Moeschler; A L Gropman; S Ashwal
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

Review 2.  High-resolution genomic microarrays for X-linked mental retardation.

Authors:  Dorien Lugtenberg; Joris A Veltman; Hans van Bokhoven
Journal:  Genet Med       Date:  2007-09       Impact factor: 8.822

3.  The renaming of mental retardation: understanding the change to the term intellectual disability.

Authors:  Robert L Schalock; Ruth A Luckasson; Karrie A Shogren; Sharon Borthwick-Duffy; Val Bradley; Wil H E Buntinx; David L Coulter; Ellis M Craig; Sharon C Gomez; Yves Lachapelle; Alya Reeve; Martha E Snell; Scott Spreat; Marc J Tassé; James R Thompson; Miguel A Verdugo; Michael L Wehmeyer; Mark H Yeager
Journal:  Intellect Dev Disabil       Date:  2007-04

Review 4.  Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation.

Authors:  Pawel Stankiewicz; Arthur L Beaudet
Journal:  Curr Opin Genet Dev       Date:  2007-04-30       Impact factor: 5.578

5.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

Review 6.  Evaluation of the child with idiopathic mental retardation.

Authors:  G B Schaefer; J B Bodensteiner
Journal:  Pediatr Clin North Am       Date:  1992-08       Impact factor: 3.278

Review 7.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

8.  American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants.

Authors:  Hutton M Kearney; Erik C Thorland; Kerry K Brown; Fabiola Quintero-Rivera; Sarah T South
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

9.  MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics.

Authors:  Tjitske Kleefstra; Helger G Yntema; Willy M Nillesen; Astrid R Oudakker; Reinier A Mullaart; Niels Geerdink; Hans van Bokhoven; Bert B A de Vries; Erik A Sistermans; Ben C J Hamel
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

Review 10.  Medical genetics: 2. The diagnostic approach to the child with dysmorphic signs.

Authors:  Alasdair G W Hunter
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

View more
  4 in total

1.  Editorial: New Horizons in Genetic Diagnosis in Pediatric Practice: The Excitement and Challenges!

Authors:  Ratna D Puri; Madhulika Kabra
Journal:  Indian J Pediatr       Date:  2016-08-11       Impact factor: 1.967

2.  Metabolic screening and its impact in children with nonsyndromic intellectual disability.

Authors:  Yasser F Ali; Salah El-Morshedy; Riad M Elsayed; Amr M El-Sherbini; Saber Am El-Sayed; Nasser Ismail A Abdelrahman; Abdulbasit Abdulhalim Imam
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-19       Impact factor: 2.570

3.  Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil.

Authors:  Ana Julia da Cunha Leite; Irene Plaza Pinto; Nico Leijsten; Martina Ruiterkamp-Versteeg; Rolph Pfundt; Nicole de Leeuw; Aparecido Divino da Cruz; Lysa Bernardes Minasi
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

4.  Derivative chromosomes involving 5p large rearranged segments went unnoticed with the use of conventional cytogenetics.

Authors:  Emiy Yokoyama; Victoria Del Castillo; Silvia Sánchez; Sandra Ramos; Bertha Molina; Leda Torres; María José Navarro; Silvia Avila; José Luis Castrillo; Benilde García-De Teresa; Bárbara Asch; Sara Frías
Journal:  Mol Cytogenet       Date:  2018-05-09       Impact factor: 2.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.